Evidence map›Paper›PMID 34830963›Full record

ArticleCancers2021

Dual-Wavelength Fluorescence Monitoring of Photodynamic Therapy: From Analytical Models to Clinical Studies.

Mikhail Kirillin, Aleksandr Khilov, Daria Kurakina, Anna Orlova, Valeriya Perekatova, Veronika Shishkova, Alfia Malygina, Anna Mironycheva, Irena Shlivko, Sergey Gamayunov and 2 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mikhail KirillinInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-6804-6369
Aleksandr KhilovInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-2075-9634
Daria KurakinaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.
Anna OrlovaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.
Valeriya PerekatovaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.
Veronika ShishkovaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.
Alfia MalyginaCenter for Skin Tumor Diagnostics and Treatment, Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Sq., 603005 Nizhny Novgorod, Russia.
Anna MironychevaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-7535-3025
Irena ShlivkoCenter for Skin Tumor Diagnostics and Treatment, Privolzhsky Research Medical University, 10/1 Minin and Pozharsky Sq., 603005 Nizhny Novgorod, Russia.
Sergey GamayunovInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-0223-0753
Ilya TurchinInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.ORCID 0000-0002-8471-7361
Ekaterina SergeevaInstitute of Applied Physics RAS, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia.

Funding

Russian Science Foundation 17-15-01264
6 · The paper itself

Abstract

Fluorescence imaging modalities are currently a routine tool for the assessment of marker distribution within biological tissues, including monitoring of fluorescent photosensitizers (PSs) in photodynamic therapy (PDT). Conventional fluorescence imaging techniques provide en-face two-dimensional images, while depth-resolved techniques require complicated tomographic modalities. In this paper, we report on a cost-effective approach for the estimation of fluorophore localization depth based on dual-wavelength probing. Owing to significant difference in optical properties of superficial biotissues for red and blue ranges of optical spectra, simultaneous detection of fluorescence excited at different wavelengths provides complementary information from different measurement volumes. Here, we report analytical and numerical models of the dual-wavelength fluorescence imaging of PS-containing biotissues considering topical and intravenous PS administration, and demonstrate the feasibility of this approach for evaluation of the PS localization depth based on the fluorescence signal ratio. The results of analytical and numerical simulations, as well as phantom experiments, were translated to the in vivo imaging to interpret experimental observations in animal experiments, human volunteers, and clinical studies. The proposed approach allowed us to estimate typical accumulation depths of PS localization which are consistent with the morphologically expected values for both topical PS administration and intravenous injection.

Indexed as

animal studieschlorin-based photosensitizersclinical studiesdual-wavelength fluorescence imaginglight transportMonte Carlo simulationsoptical phantomsphotodynamic therapy

Identifiers

PMID34830963
PMCPMC8616416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.